BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38320622)

  • 1. Hepatocellular Carcinoma Epigenetic Patterns Correspond to Differences in Ethnoracial Status and Treatment Response in a Single-Center Retrospective Study.
    Vijayakumar V; Gaba RC; Huang YH; Davis I; Roman R; Guzman G; Lokken RP; Schachtschneider KM
    J Vasc Interv Radiol; 2024 May; 35(5):731-743.e36. PubMed ID: 38320622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The DNA methylation profile of liver tumors in C3H mice and identification of differentially methylated regions involved in the regulation of tumorigenic genes.
    Matsushita J; Okamura K; Nakabayashi K; Suzuki T; Horibe Y; Kawai T; Sakurai T; Yamashita S; Higami Y; Ichihara G; Hata K; Nohara K
    BMC Cancer; 2018 Mar; 18(1):317. PubMed ID: 29566670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide DNA methylation analysis identifies candidate epigenetic markers and drivers of hepatocellular carcinoma.
    Zheng Y; Huang Q; Ding Z; Liu T; Xue C; Sang X; Gu J
    Brief Bioinform; 2018 Jan; 19(1):101-108. PubMed ID: 27760737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinformatics analysis of aberrantly methylated-differentially expressed genes and pathways in hepatocellular carcinoma.
    Sang L; Wang XM; Xu DY; Zhao WJ
    World J Gastroenterol; 2018 Jun; 24(24):2605-2616. PubMed ID: 29962817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the genome-wide DNA methylation profile of side population cells in hepatocellular carcinoma.
    Zhai JM; Yin XY; Hou X; Hao XY; Cai JP; Liang LJ; Zhang LJ
    Dig Dis Sci; 2013 Jul; 58(7):1934-47. PubMed ID: 23625283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Epigenetic Machine Learning Model to Define Risk of Progression for Hepatocellular Carcinoma Patients.
    Bedon L; Dal Bo M; Mossenta M; Busato D; Toffoli G; Polano M
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33499054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenomic profiling of DNA methylation for hepatocellular carcinoma diagnosis and prognosis prediction.
    Zhang C; Ge S; Wang J; Jing X; Li H; Mei S; Zhang J; Liang K; Xu H; Zhang X; Zhang C
    J Gastroenterol Hepatol; 2019 Oct; 34(10):1869-1877. PubMed ID: 31038805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide promoter DNA methylation profiling of hepatocellular carcinomas arising either spontaneously or due to chronic exposure to Ginkgo biloba extract (GBE) in B6C3F1/N mice.
    Kovi RC; Bhusari S; Mav D; Shah RR; Ton TV; Hoenerhoff MJ; Sills RC; Pandiri AR
    Arch Toxicol; 2019 Aug; 93(8):2219-2235. PubMed ID: 31278416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.
    Ding X; He M; Chan AWH; Song QX; Sze SC; Chen H; Man MKH; Man K; Chan SL; Lai PBS; Wang X; Wong N
    Gastroenterology; 2019 Dec; 157(6):1630-1645.e6. PubMed ID: 31560893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated analysis of methylation-driven genes and pretreatment prognostic factors in patients with hepatocellular carcinoma.
    He D; Liao S; Cai L; Huang W; Xie X; You M
    BMC Cancer; 2021 May; 21(1):599. PubMed ID: 34034705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bidirectional deep neural networks to integrate RNA and DNA data for predicting outcome for patients with hepatocellular carcinoma.
    Huang G; Wang C; Fu X
    Future Oncol; 2021 Nov; 17(33):4481-4495. PubMed ID: 34374301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
    Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
    World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation profiles reveal distinct subgroup of hepatocellular carcinoma patients with poor prognosis.
    Mah WC; Thurnherr T; Chow PK; Chung AY; Ooi LL; Toh HC; Teh BT; Saunthararajah Y; Lee CG
    PLoS One; 2014; 9(8):e104158. PubMed ID: 25093504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D receptor gene methylation in hepatocellular carcinoma.
    Abdalla M; Khairy E; Louka ML; Ali-Labib R; Ibrahim EA
    Gene; 2018 May; 653():65-71. PubMed ID: 29432829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide analysis of DNA methylation identifies novel cancer-related genes in hepatocellular carcinoma.
    Shitani M; Sasaki S; Akutsu N; Takagi H; Suzuki H; Nojima M; Yamamoto H; Tokino T; Hirata K; Imai K; Toyota M; Shinomura Y
    Tumour Biol; 2012 Oct; 33(5):1307-17. PubMed ID: 22457049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The m6A methylation landscape stratifies hepatocellular carcinoma into 3 subtypes with distinct metabolic characteristics.
    Shen X; Hu B; Xu J; Qin W; Fu Y; Wang S; Dong Q; Qin L
    Cancer Biol Med; 2020 Nov; 17(4):937-952. PubMed ID: 33299645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA Methylation Profiling of Human Hepatocarcinogenesis.
    Hernandez-Meza G; von Felden J; Gonzalez-Kozlova EE; Garcia-Lezana T; Peix J; Portela A; Craig AJ; Sayols S; Schwartz M; Losic B; Mazzaferro V; Esteller M; Llovet JM; Villanueva A
    Hepatology; 2021 Jul; 74(1):183-199. PubMed ID: 33237575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative analysis of DNA methylation and gene expression identify a six epigenetic driver signature for predicting prognosis in hepatocellular carcinoma.
    Li GX; Ding ZY; Wang YW; Liu TT; Chen WX; Wu JJ; Xu WQ; Zhu P; Zhang BX
    J Cell Physiol; 2019 Jul; 234(7):11942-11950. PubMed ID: 30536816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial differences in genome-wide methylation profiling and gene expression in breast tissues from healthy women.
    Song MA; Brasky TM; Marian C; Weng DY; Taslim C; Dumitrescu RG; Llanos AA; Freudenheim JL; Shields PG
    Epigenetics; 2015; 10(12):1177-87. PubMed ID: 26680018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter aberrant methylation status of
    Chen G; Fan X; Li Y; He L; Wang S; Dai Y; Bin C; Zhou D; Lin H
    Epigenetics; 2020; 15(6-7):684-701. PubMed ID: 31933413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.